Diabetes and Cataract Surgery: Special Considerations
Why Diabetic Patients Develop Cataracts Earlier
If you have diabetes, you may develop cataracts earlier than people without the condition, and the path to surgery requires a few additional steps to protect your eyes and your vision. According to a study published in Primary Care Diabetes in 2023, up to 20 percent of all cataract surgeries in the U.S. are performed on patients with diabetes, who face a 2 to 5 times higher risk of developing cataracts than people without diabetes (Primary Care Diabetes, 2023). The good news is that cataract surgery remains one of the safest and most successful procedures in medicine, even for patients managing diabetes. At Greenwich Ophthalmology Associates, our diabetic eye care specialist and cataract surgeons work together to coordinate every stage of your care.
When blood sugar levels remain elevated over time, excess glucose enters the lens of the eye and is converted into a sugar alcohol called sorbitol. Sorbitol draws water into the lens, causing it to swell and become cloudy. This process, known as osmotic stress, disrupts the normally transparent lens fibers and accelerates cataract formation well before it would typically occur with aging alone.
Diabetes also increases oxidative stress throughout the body, including within the eye. The lens has limited ability to repair itself once its proteins are damaged by free radicals. Over time, these damaged proteins clump together, scattering light and producing the cloudy or hazy vision characteristic of cataracts. Patients with both Type 1 and Type 2 diabetes face this elevated risk, though longer duration of diabetes and poor glycemic control increase it further.
Diabetic patients are more likely to develop posterior subcapsular cataracts, which form at the back surface of the lens and tend to affect reading vision and cause glare. Cortical cataracts, which begin as spoke-like opacities around the edges of the lens, are also seen more frequently. Both types can progress faster in patients with uncontrolled blood sugar compared to typical age-related nuclear cataracts. Learning how diabetes affects your eyes can help you understand why routine monitoring matters.
Special Risks Diabetic Patients Face During Cataract Surgery
While cataract surgery is very safe overall, diabetes introduces a few additional risk factors that require careful planning. Diabetic patients tend to have a more pronounced inflammatory response after intraocular surgery. This heightened inflammation can slow healing and increase the risk of complications such as cystoid macular edema (CME), a condition where fluid collects in the central retina after surgery. Our cataract surgeons often use extended courses of anti-inflammatory eye drops to reduce this risk.
Diabetes can impair the immune system's ability to fight off infection. Although the overall rate of post-surgical infection (endophthalmitis) is very low, diabetic patients may be slightly more vulnerable. Strict sterile technique and prophylactic antibiotic protocols help mitigate this concern. Fasting requirements before surgery can also cause blood sugar levels to swing in patients who take insulin or oral diabetes medications. Our team coordinates with your endocrinologist or primary care physician to create a medication adjustment plan so your blood sugar stays within a safe range on the day of the procedure.
Some diabetic patients have smaller pupils that do not dilate well, a condition sometimes called small pupil syndrome. Adequate dilation is important for the surgeon to access and remove the cataract safely. When needed, our cataract surgeons use specialized techniques or pupil expansion devices to achieve a safe surgical view without additional risk to surrounding structures.
How Diabetic Retinopathy Affects Cataract Surgery Planning
Many patients with diabetes also have some degree of diabetic retinopathy, and the status of the retina plays a major role in determining the timing and approach to cataract surgery. Before scheduling cataract surgery, our diabetic eye care specialist performs a thorough examination that may include optical coherence tomography (OCT) imaging and fluorescein angiography. These tests reveal whether diabetic retinopathy is present, how severe it is, and whether there is any swelling in the macula.
If proliferative diabetic retinopathy (PDR) or significant non-proliferative changes are found, treatment with anti-VEGF injections or laser therapy may be recommended before cataract surgery. Stabilizing the retina first reduces the chance that surgery will trigger further retinal complications. In some cases, the cataract itself makes it difficult for us to see and treat the retina, so the timing of each procedure must be carefully balanced.
Diabetic macular edema (DME) is swelling in the central retina caused by leaking blood vessels. If DME is present before cataract surgery, it should generally be treated and controlled first, because the inflammation from surgery can worsen existing edema. Our diabetic eye care specialist may administer one or more anti-VEGF or steroid injections in the weeks leading up to surgery to reduce macular swelling and improve the chances of a strong visual result.
Because diabetic eye disease involves both the lens and the retina, your care may involve our cataract surgeons and diabetic eye care specialist working in close coordination. This collaborative approach, with fellowship-trained subspecialists under one roof, allows us to develop a unified surgical plan and seamlessly manage both conditions throughout the process.
Should Diabetic Macular Edema Be Treated Before Cataract Surgery
The timing of DME treatment relative to cataract surgery is one of the most important decisions in managing diabetic patients who need lens replacement. Cataract surgery causes a temporary increase in inflammatory chemicals inside the eye, and these chemicals can worsen macular edema. Patients who go into surgery with active, untreated DME are at significantly higher risk for post-operative macular swelling that limits visual recovery. Pre-treating with anti-VEGF injections reduces this risk and gives the macula a healthier starting point.
In most cases, our diabetic eye care specialist recommends a series of anti-VEGF injections spaced four to six weeks apart before cataract surgery. Surgery is then scheduled once OCT imaging confirms that the macular edema has resolved or stabilized. For patients with mild or previously treated DME that is currently inactive, cataract surgery can often proceed without delay, though close monitoring afterward remains essential.
In select situations, an anti-VEGF injection or intravitreal steroid can be administered at the time of cataract surgery itself. This approach may be appropriate for patients with borderline macular edema or those who have difficulty attending multiple pre-operative appointments. Our team evaluates each patient individually to determine the safest and most effective sequence of care. Understanding the relationship between blood sugar control and eye health also plays a role in long-term DME management.
Frequently Asked Questions
Most surgeons prefer a hemoglobin A1C below 8 percent and fasting blood glucose under 200 mg/dL on the day of surgery, though exact thresholds vary based on individual health. Extremely elevated blood sugar can increase the risk of infection and slow wound healing. If your A1C is significantly above target, your surgeon may recommend working with your primary care physician to improve glucose control before scheduling the procedure.
Monofocal intraocular lenses (IOLs) are generally the most predictable choice for patients with diabetic retinopathy, because multifocal and extended depth-of-focus lenses can amplify glare and reduce contrast sensitivity in eyes with retinal changes. For diabetic patients with healthy retinas and well-controlled blood sugar, premium IOL options may still be appropriate. Our cataract surgeons assess retinal health, lifestyle goals, and long-term disease risk when making lens recommendations.
Cataract surgery can temporarily increase inflammation inside the eye, which may cause existing diabetic retinopathy or macular edema to flare. However, removing the cataract also gives your diabetic eye care specialist a much clearer view of the retina, making it easier to monitor and treat diabetic eye disease going forward. For most patients, the long-term benefits of improved vision and better retinal access outweigh the short-term inflammatory risk.
The recovery timeline is similar to that of non-diabetic patients, with most people noticing improved vision within a few days. However, diabetic patients are typically kept on anti-inflammatory eye drops for a longer period, and follow-up visits may be scheduled more frequently to monitor for macular edema or retinopathy changes. Keeping blood sugar well controlled during the weeks after surgery supports faster and smoother healing.
There is a small risk that the post-surgical inflammatory response can accelerate diabetic retinopathy progression, particularly in patients with pre-existing proliferative disease. This is why our team carefully evaluates and, when necessary, treats the retina before proceeding with cataract surgery. With proper planning and close follow-up, the vast majority of diabetic patients undergo cataract surgery without significant worsening of their retinal disease.
Diabetic patients are usually seen one day, one week, one month, and three months after surgery, with additional visits as needed based on retinal status. Because diabetes increases the risk of delayed-onset macular edema, continued monitoring beyond the standard post-operative period is important. Understanding the broader relationship between diabetes and glaucoma is also valuable, as both conditions require ongoing surveillance.
What our Patients say
4.8
Reviews
(3,408)